|
68
|
209
|
4anoA |
Crystal structure geobacillus thermodenitrificans essb cytoplasmic fragment |
|
87
|
282
|
4an9A |
Crystal structures of human mek1 with carboxamide-based allosteric inhibitor xl518 (gdc-0973), or related analogs. |
|
89
|
310
|
3zutA |
The structure of ost1 (d160a) kinase |
|
110
|
348
|
4aa5A |
P38alpha map kinase bound to cmpd 33 |
|
96
|
309
|
4ansA |
Structure of l1196m,g1269a double mutant anaplastic lymphoma kinase in complex with crizotinib |
|
109
|
347
|
4aa0A |
P38alpha map kinase bound to cmpd 2 |
|
81
|
274
|
4alvA |
Benzofuropyrimidinone inhibitors of pim-1 |
|
100
|
303
|
4ag8A |
Crystal structure of the vegfr2 kinase domain in complex with axitinib (ag-013736) (n-methyl-2-(3-((e)-2-pyridin-2-yl-vinyl)-1h- indazol-6-ylsulfanyl)-benzamide) |
|
94
|
350
|
4acgA |
Gsk3b in complex with inhibitor |
|
86
|
294
|
3zonA |
Human tyk2 pseudokinase domain bound to a kinase inhibitor |
|
80
|
298
|
4acmA |
Cdk2 in complex with 3-amino-6-(4-{[2-(dimethylamino)ethyl]sulfamoyl}-phenyl)-n-pyridin-3-ylpyrazine-2-carboxamide |
|
84
|
290
|
4aojA |
Human trka in complex with the inhibitor az-23 |
|
93
|
287
|
3zc6A |
Crystal structure of jak3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor |
|
67
|
299
|
3wzuA |
The structure of map2k7 in complex with 5z-7-oxozeaenol |
|
73
|
280
|
3wyxA |
Crystal structure of human mps1 catalytic domain in complex with 6-((3-(cyanomethoxy)-4-(1-methyl-1h-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile |
|
71
|
302
|
3wi6A |
Crystal structure of mapkap kinase-2 (mk2) in complex with non-selective inhibitor |
|
87
|
288
|
3wf9A |
Crystal structure of s6k1 kinase domain in complex with a quinoline derivative 1-oxo-1-[(4-sulfamoylphenyl)amino]propan-2-yl-2-methyl-1,2,3,4-tetrahydroacridine-9-carboxylate |
|
101
|
344
|
3zlwA |
Crystal structure of mek1 in complex with fragment 3 |
|
111
|
326
|
3w8lA |
Crystal structure of human ck2 in complex with inositol hexakisphosphate |
|
104
|
331
|
3wilA |
Crystal structure of the ck2alpha/compound3 complex |
|
77
|
298
|
3wblA |
Crystal structure of cdk2 in complex with pyrazolopyrimidine inhibitor |
|
88
|
343
|
3zh8A |
A novel small molecule apkc inhibitor |
|
78
|
283
|
3zfxA |
Crystal structure of ephb1 |
|
90
|
296
|
3zbfA |
Structure of human ros1 kinase domain in complex with crizotinib |
|
73
|
279
|
3wzjA |
Crystal structure of human mps1 catalytic domain in complex with 4-(6-(cyclohexylamino)-8-(((tetrahydro-2h-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-n-cyclopropylbenzamide |
|
118
|
334
|
3wowA |
Crystal structure of human ck2a with amppnp |
|
100
|
343
|
3zlyA |
Crystal structure of mek1 in complex with fragment 8 |
|
90
|
292
|
3wf7A |
Crystal structure of s6k1 kinase domain in complex with a purine derivative 1-(9h-purin-6-yl)-n-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide |
|
91
|
293
|
3zc5A |
X-ray structure of c-met kinase in complex with inhibitor (s)-6-(1-(6- (1-methyl-1h-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)ethyl) quinoline. |
|
94
|
298
|
3wzdA |
Kdr in complex with ligand lenvatinib |
|
97
|
303
|
3wzeA |
Kdr in complex with ligand sorafenib |
|
82
|
274
|
3zfyA |
Crystal structure of ephb3 |
|
72
|
279
|
3wzkA |
Crystal structure of human mps1 catalytic domain in complex with n-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide |
|
116
|
334
|
3wikA |
Crystal structure of the ck2alpha/compound10 complex |
|
88
|
287
|
3zmmA |
Inhibitors of jak2 kinase domain |
|
87
|
290
|
3wf5A |
Crystal structure of s6k1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1h-benzimidazol-2-yl)piperidin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine |
|
99
|
349
|
3zdiA |
Glycogen synthase kinase 3 beta complexed with axin peptide and inhibitor 7d |
|
76
|
280
|
3zewA |
Crystal structure of ephb4 in complex with staurosporine |
|
78
|
279
|
3zfmA |
Crystal structure of ephb2 |
|
93
|
293
|
3zclA |
X-ray structure of c-met kinase in complex with inhibitor (s)-3-(1-(1h-pyrrolo(2,3-b)pyridin-3-yl)ethyl)-n-isopropyl-(1,2,4)triazolo(4,3- b)pyridazin-6-amine |
|
72
|
280
|
3wyyA |
Crystal structure of human mps1 catalytic domain in complex with (e)-3-(4-((6-(((3s,5s,7s)-adamantan-1-yl)amino)-4-amino-5-cyanopyridin-2-yl)amino)-2-(cyanomethoxy)phenyl)-n-(2-methoxyethyl)acrylamide |
|
104
|
344
|
3zlsA |
Crystal structure of mek1 in complex with fragment 6 |
|
89
|
288
|
3wf8A |
Crystal structure of s6k1 kinase domain in complex with a quinoline derivative 2-oxo-2-[(4-sulfamoylphenyl)amino]ethyl 7,8,9,10-tetrahydro-6h-cyclohepta[b]quinoline-11-carboxylate |
|
84
|
290
|
3wf6A |
Crystal structure of s6k1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1h-indol-3-yl)-3,6-dihydropyridin-1(2h)-yl]-1h-pyrazolo[3,4-d]pyrimidine |
|
101
|
344
|
3zlxA |
Crystal structure of mek1 in complex with fragment 18 |
|
94
|
344
|
3w8qA |
Structure of the human mitogen-activated protein kinase kinase 1 (mek1) |
|
84
|
285
|
3zepA |
Crystal structure of jak3 kinase domain in complex with a pyrrolopyrazine-2-phenyl ether inhibitor |
|
85
|
288
|
3wigA |
Human mek1 kinase in complex with ch5126766 and mgamp-pnp |
|
90
|
290
|
3we4A |
Crystal structure of s6k1 kinase domain in complex with a pyrimidine derivative pf-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1h-benzimidazole |
|
97
|
343
|
3zm4A |
Crystal structure of mek1 in complex with fragment 1 |
